Daniel B. Mark MD MPH

Cardiac Critical Care

Professor of Medicine, Duke University School of Medicine

2100 Erwin RdDurham, NC 27705
Phone+1 919-620-4467

Dr. Mark is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mark's full profile Already have an account?

Summary

Dr. Daniel Mark is a cardiologist in Durham, NC and is affiliated with Duke University Hospital. He received his medical degree from Tufts University School of Medicine and has been in practice 39 years. He specializes in cardiac critical care and is experienced in general cardiology.

Education & Training

Duke University HospitalFellowship, Cardiovascular Disease, 1982 - 1985
University of Virginia Medical CenterResidency, Internal Medicine, 1979 - 1982
Tufts University School of MedicineClass of 1978

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 1981 - 2027
NC State Medical License 1982 - 2027
FL State Medical License 2014 - 2020
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Elected Member The American Society for Clinical Investigation, 1998
Fellow (FACC) American College of Cardiology

Clinical Trials

Comparison of Surgical and Medical Treatment for Congestive Heart Failure and Coronary Artery Disease
COMPLETED
PHASE3
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial Start of enrollment: 2009 Nov 13
COMPLETED
NA
Trial to Assess Chelation Therapy 2 Start of enrollment: 2016 Oct 01
COMPLETED
PHASE3

Publications & Presentations

PubMed

The Importance of Age in Selecting a Testing Strategy for Stable Symptomatic Patients With Suspected Coronary Artery Disease.
Evangelia Vemmou, Michelle D Kelsey, Sreekanth Vemulapalli, Daniel B Mark, Campbell Rogers
Journal of the American Geriatrics Society. 2026-06-01
Choosing Between CABG and PCI for 3-Vessel Coronary Disease: What's Cost Got to Do With It?
Daniel B Mark, Sunil V Rao
Journal of the American College of Cardiology. 2026-04-28
Use of coronary artery bypass graft surgery and percutaneous coronary intervention and associated outcomes in the ISCHEMIA trial.
Harvey D White, Sean M O'Brien, William E Boden, Stephen E Fremes, Sripal Bangalore
American Heart Journal. 2025-11-01

Journal Articles

Original Investigation Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure
Lawton S Cooper, Ileana L Pina, David J Whellan, Daniel B Mark, Kirkwood F Adams, ScienceDirect
New Research Paper Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy with Validated Patient-Centric Risk Estimates
Jeanne E Poole, Todd F Dardas, Gust H Bardy, Ramin Shadman, Wayne C Levy, Daniel B Mark, ScienceDirect

Lectures

Quality of Life and Cost-Effectiveness Associated with the Late Opening of a Total Occluded Artery
American Heart Association, Scientific Sessions 2007, Orlando, Florida, USA
Quality of Life and Cost-Effectiveness Associated with the Late Opening of a Total Occluded Artery
Scientific Sessions 2007, Orlando, Florida, USA

Press Mentions

Dapagliflozin’s Cost-Effectiveness ‘Intermediate’ for HFrEFJune 3rd, 2021
Clinical Practice Guideline: Full Text 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesDecember 17th, 2020
Medicine Today: A Look a Treatment of Atrial FibrillationApril 29th, 2019

Grant Support

2/2 Catheter Ablation Versus Antiarrhythmic and Heart Failure Drug Therapy in Preserved Ejection Fraction Heart Failure (CABANA-HF)DUKE UNIVERSITY2026–2033
RACE-CARS DCC 2/2DUKE UNIVERSITY2020–2027
Trial to Assess Chelation Therapy 2 (TACT2) DCC Competing RenewalDUKE UNIVERSITY2015–2025
Postdoctoral Training in Cardiovascular Clinical ResearchDUKE UNIVERSITY2003–2025
The Ischemia Trial - EqolNational Heart, Lung, And Blood Institute2011–2012